Showing results (81-90 of 91) with videos related to
Sort By:
Pageof 10
Archives of Pathology & Laboratory Medicine|September 4, 2020
Conventional Cytogenetic Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics CommitteeDaniel P Larson, Yassmine M Akkari, Daniel L Van Dyke, et al.Cancer Genetics and Cytogenetics|December 16, 2010
Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research ConsortiumStephanie A Smoley, Daniel L Van Dyke, Neil E Kay, et al.Blood Cancer Journal|May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndromeYucai Wang, Sutapa Sinha, Linda E Wellik, et al.The Oncologist|September 5, 2020
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic LeukemiaPaul J Hampel, Timothy G Call, Kari G Rabe, et al.Leukemia Research|November 19, 2025
Genomic profiling reveals molecular heterogeneity in patients with Richter transformation (RT) and chronic lymphocytic leukemia (CLL)Shulan Tian, Hanyin Wang, Sameer A Parikh, et al.European Journal of Haematology|October 2, 2018
Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemiaUmut Aypar, Stephanie A Smoley, Beth A Pitel, et al.American Journal of Hematology|December 22, 2018
IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomesHong Fang, Kaaren K Reichard, Kari G Rabe, et al.JAMA|April 11, 2013
Long QT syndrome-associated mutations in intrauterine fetal deathLia Crotti, David J Tester, Wendy M White, et al.Blood Cancer Journal|September 1, 2022
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinibPaul J Hampel, Kari G Rabe, Timothy G Call, et al.Blood Advances|March 6, 2023
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLLRosalie Griffin, Julia E Wiedmeier-Nutor, Sameer A Parikh, et al.Pageof 10